India's largest platform and marketplace for GCCs & AI

Sign in

India's largest platform and marketplace for GCCs & AI

3AI Digital Library

AI in Insurance: Applications and Adoption , the road ahead

September 20, 2020

Dwiraj Bose
Senior Vice President – Analytics at Bajaj Allian
z

for their organisations and customer engagement and how AI is playing a role?discuss the vast potential for AI in the insurance space, from theoretical insights to practical implementations. What insurers are doing in terms of using AI to create value in their organizations and to engage with customers better?

    3AI Trending Articles

  • IIT Delhi Offers Free Online Course on AI

    IIT Delhi is offering a free online 12-week programme on Artificial Intelligence with a certificate on completion. Indian Institute of Technology (IIT) Delhi is inviting registrations from those who would like to enrol for a 12-week long free online course on Artificial Intelligence. This programme will be offered on the National Programme on Technology Enhanced […]

  • Reimagine Business Strategy & Operating Models with AI : The CXO’s Playbook

    Author: Sameer Dhanrajani, CEO at AIQRATE advisory & consulting | AI advisor, business builder | Author | Speaker |Columnist| President at 3AI | Ex-CSO: Fractal, Global Business Leader: Cognizant, Country Head: Fidelity National Financial AlphaGo caused a stir by defeating 18-time world champion Lee Sedol in Go, a game thought to be impenetrable by AI […]

  • P&L Forecasting Enabled by Analytics

    Author: Rajagopal Rangarajan, Senior Manager – Analytics, AB InBev Accurate P&L forecasts help companies build a good financial plan for the year. It enables the financial planning team in allocating resources more meaningfully across the company. For large and highly leveraged companies like AB-InBev with annual Revenues more than $50 Bn and with a debt […]

  • AI in Drug Discovery

    Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]